Staurosporine-induced G2/M arrest in primary effusion lymphoma BCBL-1 cells.
Wang
Yi-Fen
YF
Department of Medical Technology, Fooyin University, 151 Chin-Hsuen Road, Ta-Liao, Kaohsiung Hsien, Taiwan, Republic of China. yfwang@mail.fy.edu.tw
Hsieh
Yu-Fang
YF
Lin
Chin-Lin
CL
Lin
Jing-Li
JL
Chen
Chang-Yu
CY
Chiou
Yee-Hsuan
YH
Chou
Miao-Chen
MC
D016203:CDC2 Protein Kinase / Q000378:metabolism; D005871:Castleman Disease / Q000188:drug therapy / Q000473:pathology / Q000821:virology; D002455:Cell Division / Q000187:drug effects*; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects; D019926:Cyclin B / Q000378:metabolism; D004267:DNA Viruses / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D016195:G2 Phase / Q000187:drug effects*; D019288:Herpesvirus 8, Human; D006801:Humans; D016393:Lymphoma, B-Cell / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology / Q000821:virology; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000378:metabolism; D012514:Sarcoma, Kaposi / Q000188:drug therapy / Q000473:pathology / Q000821:virology; D019311:Staurosporine / Q000494:pharmacology*; D014779:Virus Replication / Q000187:drug effects
D019926:Cyclin B; D004791:Enzyme Inhibitors; D011493:Protein Kinase C; D016203:CDC2 Protein Kinase; D019311:Staurosporine